Financial Ratios

BAJAJ HEALTHCARE LTD.

NSE : BAJAJHCAREBSE : 539872ISIN CODE : INE411U01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE326.70-2.8 (-0.85 %)
PREV CLOSE ( ) 329.50
OPEN PRICE ( ) 330.25
BID PRICE (QTY) 326.70 (2554)
OFFER PRICE (QTY) 327.00 (200)
VOLUME 6350
TODAY'S LOW / HIGH ( )325.15 331.15
52 WK LOW / HIGH ( )245.05 511
NSE327.15-1.3 (-0.4 %)
PREV CLOSE( ) 328.45
OPEN PRICE ( ) 330.95
BID PRICE (QTY) 326.60 (21)
OFFER PRICE (QTY) 327.05 (3)
VOLUME 28393
TODAY'S LOW / HIGH( ) 325.55 331.45
52 WK LOW / HIGH ( )275.7 513.4
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)15.5925.8760.2318.2923.64
   CEPS(Rs)25.5032.2635.9613.5410.04
   DPS(Rs)1.001.502.750.000.00
   Book NAV/Share(Rs)133.23119.02187.26128.94128.82
   Tax Rate(%)26.1020.4030.0530.0232.52
Margin Ratios
   Core EBITDA Margin(%)15.8917.4520.7611.7811.60
   EBIT Margin(%)12.0615.0719.3510.418.78
   Pre Tax Margin(%)8.6513.1918.098.796.53
   PAT Margin (%)6.3910.5012.656.164.41
   Cash Profit Margin (%)10.4513.0915.109.117.49
Performance Ratios
   ROA(%)5.3011.4519.148.286.10
   ROE(%)12.3624.3338.0918.9220.18
   ROCE(%)11.8820.0035.9119.4719.75
   Asset Turnover(x)0.831.091.511.341.38
   Sales/Fixed Asset(x)1.451.862.201.671.71
   Working Capital/Sales(x)9.148.928.6713.3118.66
Efficiency Ratios
   Fixed Capital/Sales(x)0.690.540.450.600.58
   Receivable days111.6576.0754.8278.6178.15
   Inventory Days99.7668.8237.8930.8631.41
   Payable days86.8378.1361.0660.6468.01
Valuation Parameters
   PER(x)19.5513.163.925.624.49
   PCE(x)11.9510.556.567.6010.58
   Price/Book(x)2.292.862.521.593.30
   Yield(%)0.330.440.580.000.00
   EV/Net Sales(x)1.841.761.240.901.13
   EV/Core EBITDA(x)11.409.945.706.768.34
   EV/EBIT(x)15.2411.656.438.6811.27
   EV/CE(x)1.371.661.561.081.37
   M Cap / Sales1.251.380.990.690.90
Growth Ratio
   Net Sales Growth(%)-0.973.4960.2426.1512.27
   Core EBITDA Growth(%)-9.61-16.18161.4024.875.77
   EBIT Growth(%)-20.75-19.42197.8631.416.80
   PAT Growth(%)-39.73-14.11229.3254.737.40
   EPS Growth(%)-39.73-57.05229.32-22.647.40
Financial Stability Ratios
   Total Debt/Equity(x)1.130.780.700.510.91
   Current Ratio(x)1.171.241.411.221.17
   Quick Ratio(x)0.690.740.880.940.91
   Interest Cover(x)3.538.0215.256.443.91
   Total Debt/Mcap(x)0.490.270.280.320.28

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.